Treatment of corneal ulcers. What are the medical options?

Journal of Feline Medicine and Surgery

Volumn 12, Issue 5, 2010, Pages 384-397

  Hartley, Claudia ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CORNEA ULCER; HERPES VIRUS; HERPES VIRUS INFECTION; ISOLATION AND PURIFICATION; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CAT DISEASES; CATS; CORNEAL ULCER; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS;

FELID HERPESVIRUS 1; FELIDAE; HERPESVIRIDAE;

EID: 77953750383     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2010.03.012     Document Type: Article

References (107)

1. Hartley C. Aetiology of corneal ulcers. Assume FHV-1 unless proven otherwise. J Feline Med Surg 2010; 12: 24-35.
2. Hollingsworth SR, Canton DD, Buyukmihci NC, Farver TB. Effect of topically administered atropine on tear production in dogs. J Am Vet Med Assoc 1992; 200: 1481-84.
3. Shewen PE, Povey RC, Wilson MR. A survey of the conjunctival flora of clinically normal cats and cats with conjunctivitis. Can Vet J 1980; 21: 231-33.
4. Campbell LH, Fox JG, Snyder SB. Ocular bacteria and mycoplasma of the clinically normal cat. Feline Pract 1973; 3: 10-12.4
5. Gerding PA, Kakoma I. Microbiology of the canine and feline eye. Vet Clin North Am Small Anim Pract 1990; 20: 615-25.
6. Gray LD, Ketring KL, Tang YW. Clinical use of 16S rRNA gene sequencing to identify Mycoplasma felis and M. gateae associated with feline ulcerative keratitis. J Clin Microbiol 2005; 43: 3431-34.
7. Haesebrouck F, Devriese LA, van Rijssen B, Cox E. Incidence and significance of isolation of Mycoplasma felis from conjunctival swabs of cats. Vet Microbiol 1991; 26: 95-101.
8. Campbell LH, Snyder SB, Reed C, Fox JG. Mycoplasma felis-associated conjunctivitis in cats. J Am Vet Med Assoc 1973; 163: 991-95.
9. Cole BC, Golightly L, Ward JR. Characterization of mycoplasma strains from cats. J Bacteriol 1967; 94: 1451-58.
10. Ledbetter EC, Scarlett JM. Isolation of obligate anaerobic bacteria from ulcerative keratitis in domestic animals. Vet Ophthalmol 2008; 11: 114-22.
11. Lin N, Gong XM, Xie QJ, Shao MR. Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture. Eye Science 1989; 5: 32-35.
12. Alfonso EC, Albert DM, Kenyon KR, Robinson NL, Hanninen L, D'Amico DJ. In vitro toxicity of gentamicin to corneal epithelial cells. Cornea 1990; 9: 55-61.
13. Lin CP, Boehnke M. Effect of fortified antibiotic solutions on corneal epithelial wound healing. Cornea 2000; 19: 204-6.
14. Matsumoto S, Stern ME. Effect of anti-infective ophthalmic solutions on corneal cells in vitro. Adv Ther 2000; 17: 148-51.
15. Cutarelli PE, Lass JH, Lazarus HM, Putman SC, Jacobs MR. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity. Curr Eye Res 1991; 10: 557-63.
16. Kusano M, Uematsu M, Kumagami T, Sasaki H, Kitaoka T. Evaluation of acute corneal barrier change induced by topically applied preservatives using corneal transepithelial electric resistance in vivo. Cornea 2010; 29: 80-85.
17. Aronowicz JD, Shine WE, Oral D, Vargas JM, McCuleey JP. Short term oral minocycline treatment of meibomianitis. Br J Ophthalmol 2006; 90: 856-60.
18. Souchier M, Joffre C, Gregoire S, et al. Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment. Br J Ophthalmol 2008; 92: 819-22.
19. Dougherty JM, McCulley JP, Silvany RP, Meyer DR. The role of tetracyclines in chronic blepharitis - inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 1991; 32: 2970-75.
20. Smith VA, Khan-Lim D, Andreson L, Cook SD, Dick AD. Does orally administered doxycycline reach the tear film? Br J Ophthalmol 92: 856-59.
21. Hartmann A, Krebber R, Daube G, Hartmann K. Pharmacokinetics of pradofloxacin and doxycycline in serum, saliva, and tear fluid of cats after oral administration. J Vet Pharmacol Ther 2008; 31: 87-94.
22. Baker A, Plummer CE, Szabo NG, Barrie KP, Brooks DE. Doxycycline levels in preocular tear film of horses following oral administration. Vet Ophthalmol 2008; 11: 381-85.
23. Iovieno A, Lambiase A, Micera A, Stampachiacchiere B, Sqrulleta R, Bonini S. In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis. Eur J Ophthalmol 2009; 19: 708-16.
24. Ollivier FJ, Brooks DE, Kallberg ME, et al. Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis. Am J Vet Res 2003; 64: 1081-87.
25. Moyaert H, De Graef EM, Haesebrouck F, Decostere A. Acquired antimicrobial resistance in the intestinal microbiota of diverse cat populations. Res Vet Sci 2006; 81: 1-7.
26. Winckler K. Tetracycline ulcers of the oesophagus, endoscopy, histology and roentgenology in two cases, and review of the literature. Endoscopy 1981; 13: 225-28.
27. Melandez L, Twedt D, Wright M. Suspected doxycycline-induced oesophagitis with oesophageal stricture formation in three cats. Feline Pract 2000; 28: 10-12.
28. McGrotty YL, Knottenbelt CM. Oesophageal stricture in a cat due to oral administration of tetracyclines. J Small Anim Pract 2002; 43: 221-23.
29. German AJ, Cannon MJ, Dye C, et al. Oesophageal strictures in cats associated with doxycycline therapy. J Feline Med Surg 2005; 7: 33-41.
30. Majcherczyk J, Szymanska-Jachimczak EI. Discoloration of the teeth and bones in young animals caused by tetracycline. Zahnarztl Prax 1965; 16: 61-63.
31. Kern TJ. Antibacterial agents for ocular therapeutics. Vet Clin North Am Small Anim Pract 2004; 34: 655-68.
32. Owen WM, Sturgess CP, Harbour DA, Egan K, Gruffyd-Jones TJ. Efficacy of azithromycin for the treatment of feline chlamydophilosis. J Feline Med Surg 2003; 5: 305-11.
33. Ruch-Gallie RA, Veir JK, Spindel ME, Lappin MR. Efficacy of amoxycillin and azithromycin for the empirical treatment of shelter cats with suspected bacterial upper respiratory infections. J Feline Med Surg 2008; 10: 542-50.
34. Gelatt KC, van der Woerdt A, Ketring KL, et al. Enrofloxacinassociated retinal degeneration in cats. Vet Ophthalmol 2001; 4: 99-106.
35. Regnier A. Clinical pharmacology and therapeutics Part 2: Antimicrobials, anti-inflammatory agents and antiglaucoma drugs. In: Gelatt KN, ed. Veterinary ophthalmology. 4th edn. Iowa, USA; Blackwell Publishing, 2007; 288-321.
36. Labelle AL, Hamor RE, Barger AM, Maddox CW, Breaux CB. Aspergillus flavus keratomycosis in a cat treated with topical 1% voriconazole solution. Vet Ophthalmol 2009; 12: 48-52.
37. Thomas PA. Fungal infections of the cornea. Eye 2003; 17: 852-62.
38. Manzouri B, Vafidis GC, Wyse RK. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacother 2001; 2: 1849-57.
39. Scotty NC. Equine keratomycosis. Clin Tech Equine Pract 2005; 4: 29-36.
40. Millichamp NJ. Ocular trauma. Vet Clin North Am Equine Pract 1992; 8: 521-36.
41. Nasisse MP. Equine ulcerative keratitis. Vet Clin North Am Equine Pract 1992; 8: 537-55.
42. Gaarder JE, Rebhun WC, Ball MA, Patten V, Shin S, Erb H. Clinical appearances, healing patterns, risk factors, and outcomes of horses with fungal keratitis: 53 cases (1978-1996). J Am Vet Med Assoc 1998; 213: 105-112.
43. Ford MM. Antifungals and their use in veterinary ophthalmology. Vet Clin North Am Small Anim Pract 2004; 34: 669-91.
44. Haffner JC, Fecteau KA, Eiler H. Inhibition of collagenase breakdown of equine corneas by tetanus antitoxin, equine serum and acetylcysteine. Vet Ophthalmol 2003; 6: 67-72.
45. Brooks DE. When to use adjunctive treatments for equine keratopathies. Presentation at British Equine Veterinary Association (BEVA) 2009; Birmingham, UK.
46. Nasisse MP, Davis BJ, Guy JS. Isolation of feline herpesvirus 1 from the trigeminal ganglia of acutely and chronically infected cats. J Vet Intern Med 1992; 6: 102-3.
47. Gaskell RM, Povey RC. Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Vet Rec 1977; 100: 128-133.
48. Maggs DJ. Update on pathogenesis, diagnosis, and treatment of feline herpesvirus type 1. Clin Tech Small Anim Pract 2005; 20: 94-101.
49. Nasisse MP, Guy J, Davidson M, Sussman WA, Fairley NM. Experimental ocular herpesvirus infection in the cat. Invest Ophthalmol Vis Sci 1989; 30: 1758-68.
50. Thiry E, Addie D, Belak S, et al. Feline herpesvirus infection. ABCD guidelines on prevention and management. J Feline Med Surg 2009; 11: 547-55.
51. Stiles J. Feline herpesvirus. Vet Clin North Am Small Anim Pract 2000; 30: 1001-14.
52. Nasisse MP. Manifestations, diagnosis and treatment of ocular herpesvirus infection in the cat. Compend Contin Educ Pract Vet 1982; 4: 962-70.
53. La Croix NC, van de Woerdt A, Olivero DK. Nonhealing ulcers in cats: 29 cases (1991-1999). J Am Vet Med Assoc 2001; 218: 733-35.
54. Maggs DJ, Clarke HE. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Am J Vet Res 2004; 65: 400-3.
55. Fontenelle JP, Powell CC, Veir JK, Radecki SV, Lappin MR. Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. Am J Vet Res 2008; 69: 289-93.
56. Nasisse MP, Guy JS, Davidson MG, Sussman W, de Clercq E. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine. Am J Vet Res 1989; 50: 158-60.
57. Williams DL, Fitzmaurice T, Lay L, et al. Efficacy of antiviral agents in feline herpetic keratitis: results of an in vitro study. Curr Eye Res 2004; 29: 215-18.
58. Stiles J. Treatment of cats with ocular disease attributable to herpesvirus infection: 17 cases (1983-1993). J Am Vet Med Assoc 1995; 205: 599-603.
59. Malik R, Lessels NS, Webb S, et al. Treatment of feline herpesvirus-1 associated disease in cats with famciclovir and related drugs. J Feline Med Surg 2009; 11: 40-48.
60. Owens JG, Nasisse MP, Tadepalli SM, Dorman DC. Pharmacokinetics of acyclovir in the cat. J Vet Pharmacol Ther 1996; 19: 488-490.
61. Nasisse MP, Dorman DC, Jamison KC, Weigler BJ, Hawkins EC, Stevens JB. Effects of valacyclovir in cats infected with feline herpesvirus 1. Am J Vet Res 1997; 58: 1141-44.
62. Filer CW, Ramji JV, Allen GD, et al. Metabolic and pharmaco - kinetic studies following oral administration of famciclovir to the rat and dog. Xenobiotica 1995; 25: 477-90.
63. Thomasy SM, Maggs DJ, Moulin NK, Stanley SD. Pharmacokinetics and safety of penciclovir following oral administration of famciclovir to cats. Am J Vet Res 2007; 68: 1252-58.
64. Thomasy SM, Whittem T, Stanley SD, Maggs DJ. Pharmacokinetics of famciclovir and penciclovir following singledose oral administration of famciclovir to cats. Abstract presentation at American College of Veterinary Ophthalmologists 2009; Chicago, USA.
65. Eid P, Meritet JP, Maury C, Lasfar A, Weill D, Tovey MG. Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics. J Interferon Cytokine Res 1999; 19: 157-69.
66. Siebeck N, Hurley DJ, Garcia M, et al. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1. Am J Vet Res 2006; 67: 1406-11.
67. Bracklein T, Theise S, Metzler A, Spiess BM, Richter M. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells. J Am Vet Med Assoc 2006; 67: 1025-32.
68. Haid C, Kaps S, Gönczi E, et al. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats. Vet Ophthalmol 2007; 10: 278-84.
69. Van der Meulen K, Garre B, Croubels S, Nauwynck H. In vitro comparison of antiviral drugs against feline herpesvirus 1. BMC Vet Res 2006; 2. doi:10.1186/1746-6148-2-13
70. Gutzwiller ME, Brachelente C, Taglinger K, Suter MM, Weissenböck H, Roosje PJ. Feline herpes dermatitis treated with interferon omega. Vet Dermatol 2007; 18: 50-54.
71. Stiles J, Townsend WM, Rogers QR, Krohne SG. Effect of oral administration of L-lysine on conjunctivitis caused by feline herpesvirus in cats. Am J Vet Res 2002; 63: 99-103.
72. Maggs DJ, Collins BK, Thorne JG, Nasisse MP. Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1. Am J Vet Res 2000; 61: 1474-78.
73. Morris JG. Nutritional and metabolic responses to arginine deficiency in carnivores. J Nutr 1985; 115: 524-31.
74. Rogers QR, Phang JM. Deficiency of pyrroline-5-carboxylate synthase in the intestinal mucosa of the cat. J Nutr 1985; 115: 146-150.
75. Rees TM, Lubinski JL. Oral supplementation with L-lysine did not prevent upper respiratory infection in a shelter population of cats. J Feline Med Surg 2008; 10: 510-13.
76. Maggs DJ, Sykes JE, Clarke HE, et al. Effects of dietary lysine supplementation in cats with enzootic upper respiratory disease. J Feline Med Surg 2007; 9: 97-108.
77. Drazenovich TL, Fascetti AJ, Westermeyer HD, et al. Effects of dietary lysine supplementation on upper respiratory and ocular disease and detection of infectious organisms in cats within an animal shelter. Am J Vet Res 2009; 70: 1391-1400.
78. Fascetti AJ, Maggs DJ, Kanchuk ML, Clarke HE, Rogers QR. Excess dietary lysine does not cause lysine-arginine antagonism in adult cats. J Nutr 2004; 134: 2042-45.
79. Lappin MR, Veir J, Hawley J. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines. J Feline Med Surg 2008; 11: 159-62.
80. Cocker FM, Newby TJ, Gaskell RM, et al. Responses of cats to nasal vaccination with a live, modified feline herpesvirus type 1. Res Vet Sci 1986; 41: 323-30.
81. Weigler J, Guy JS, Nasisse MP, Hancock SI, Sherry B. Effect of a live attenuated intranasal vaccine on latency and shedding of feline herpesvirus 1 in domestic cats. Arch Virol 1997; 142: 2389-400.
82. Kanellos T, Sutton DJ, Salisbury CF, Chalmers WSK. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogns. J Feline Med Surg 2008; 10: 346-54.
83. Scott FW, Geissinger CM. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am J Vet Res 1999; 60: 652-58.
84. Fischer SM, Quest CM, Dubovi EJ, et al. Response of feral cats to vaccination at the time of neutering. J Am Vet Med Assoc 2007; 230: 52-58.
85. Schultz R. Duration of immunity for canine and feline vaccines: a review. Vet Microbiol 2006; 117: 75-79.
86. Sparkes AH. Feline vaccination protocols: is a consensus emerging? Schweiz Arch Tierheilkd 2010; 152: 135-40.
87. Gaskell R, Dawson S, Radford A, Thiry E. Feline herpesvirus. Vet Rec 2007; 38: 337-54.
88. Nasisse MP, English RV, Tompkins MB, Guy JS, Sussman W. Immunologic, histologic, and virologic features of herpesvirusinduced stromal keratitis in cats. Am J Vet Res 1995; 56: 51-55.
89. Johnson LR, Foley JE, De Cock HEV, Clarke HE, Maggs DJ. Assessment of infectious organisms associated with chronic rhino sinusitis in cats. J Am Vet Med Assoc 2005; 227: 580-85.
90. Andrew SE. Immune-mediated canine and feline keratitis. Vet Clin North Am Small Anim Pract 2008; 38: 269-90.
91. Hendricks RL, Barfknecht CF, Schoenwald RD, Epstein RJ, Sugar J. The effect of flurbiprofen on herpes simplex virus type 1 stromal keratitis in mice. Invest Ophthalmol Vis Sci 1990; 31: 1503-11.
92. Rao SN. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Am J Ophthalmol 2006; 141: 771-72.
93. Speiss AK, Sapienza JS, Mayordomo A. Treatment of proliferative feline eosinophilic keratitis with topical 1.5% cyclosporine: 35 cases. Vet Ophthalmol 2009; 12: 132-37.
94. Bekendam PD, Narváez J, Agarwal M. Case of corneal melting associated with the use of topical nepafenac. Cornea 2007; 26: 1002-3.
95. Feiz V, Oberg TJ, Kurz CJ, Mamalis N, Moshirfar M. Nepafenacassociated bilateral corneal melt after photorefractive keratectomy. Cornea 2009; 28: 948-50.
96. Van Alphen GW, Macri FJ. Entrance of fluorescein into aqueous humour of cat eye. Arch Ophthalmol 1966; 75: 247-53.
97. Maggs DJ, Lappin MR, Nasisse MP. Detection of feline herpesvirus- specific antibodies and DNA in aqueous humor from cats with or without uveitis. Am J Vet Res 1999; 60: 932-36.
98. Poirier RH, Kingham JD, de Miranda P, Annel M. Intraocular anti - viral penetration. Arch Ophthalmol 1982; 100: 1964-67.
99. Nasisse MP, Glover TL, Moore CP, Weigler BJ. Detection of feline herpesvirus 1 DNA in corneas of cats with eosinophilic keratitis or corneal sequestration. Am J Vet Res 1998; 59: 856-58.
100. Allgoewer I, Schaeffer EH, Stockhaus C, Vogtlin A. Feline eosinophilic conjunctivitis. Vet Ophthalmol 2001; 4: 69-74.
101. Krukelhorn R, Schrage N, Keller G, Redbrake C. Emergency treatment of chemical and thermal eye burns. Acta Ophthalmol (Copenh) 2002; 80: 4-10.
102. Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 1997; 41: 275-313.
103. Reim M, Redbrake C, Schrage N. Chemical and thermal injuries of the eyes. Surgical and medical treatment based on clinical and pathophysiological findings. Arch Soc Esp Oftalmol 2001; 76: 79-124.
104. Ghasemi H, Ghazanfari T, Ghassemi-Broumand M, et al. Longterm ocular consequences of sulfur mustard in seriously eyeinjured war veterans. Cutan Ocul Toxicol 2009; 28: 71-77.
105. Zhao B, Ma A, Martin FL, Fullwood NJ. An investigation into corneal alkali burns using an organ culture model. Cornea 2009; 28: 541-46.
106. Michau TM, Gilger BC, Maggio F, Davidson MG. Use of thermo - keratoplasty for treatment of ulcerative keratitis and bullous keratopathy secondary to corneal endothelial disease in dogs: 13 cases (1994-2001). J Am Vet Med Assoc 2003; 222: 607-12.
107. Knezovic I, Dekaris I, Gabric N, et al. Therapeutic efficacy of 5% NaCl hypertonic solution in patients with bullous keratopathy. Coll Antropol 2006; 30: 405-8.